Goldman Sachs Group Inc Legend Biotech Corp Put Options Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$32.49 - $50.28 $263,169 - $407,268
-8,100 Reduced 10.45%
69,400 $2.26 Million
Q2 2024

Aug 13, 2024
BUY
$39.5 - $57.22 $1.87 Million - $2.71 Million
47,300 Added 156.62%
77,500 $3.43 Million
Q1 2024

May 15, 2024
SELL
$55.06 - $69.99 $996,586 - $1.27 Million
-18,100 Reduced 37.47%
30,200 $1.69 Million
Q2 2023

Aug 14, 2023
BUY
$46.28 - $75.01 $2.24 Million - $3.62 Million
48,300 New
48,300 $3.33 Million

Others Institutions Holding LEGN

# of Institutions
227
Shares Held
76.3M
Call Options Held
199K
Put Options Held
342K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.8B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email